Advanced Medical Solutions ( (GB:AMS) ) has provided an announcement.
Advanced Medical Solutions Group plc (AMS) has acknowledged an announcement by Montagu Private Equity LLP regarding a potential offer for the company. However, AMS has not received a formal proposal, and there is no certainty that an offer will be made. The company is now in an ‘offer period’ as per the City Code on Takeovers and Mergers, with Montagu required to make a decision by April 24, 2025. This development places AMS under scrutiny, potentially impacting its market positioning and shareholder interests.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer specializing in innovative tissue-healing technology. The company offers a wide range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and sealants under various brand names such as LiquiBand, RESORBA, and Seal-G. AMS also provides wound care dressings and has expanded its operations through multiple acquisitions since 2019. The company’s products are manufactured across several countries and sold globally through a network of partners and direct sales forces.
YTD Price Performance: 0.51%
Average Trading Volume: 703,376
Technical Sentiment Signal: Strong Buy
Current Market Cap: £425.7M
See more data about AMS stock on TipRanks’ Stock Analysis page.